Teva launches Copaxone with the YpsoMate autoinjector from Ypsomed - Ypsomed - Canada
Teva faces EU antitrust probe over MS drug Copaxone -
FDA approves first MS drug for aggressive multiple sclerosis: ocrelizumab (Ocrevus) - CBS News
What are the implications of a generic Teva MS drug? Here's what the wags say - STAT
Teva knocked as competition fears grow for MS drug | Financial Times
18. Teva Pharmaceutical Industries | FiercePharma
Teva Found Liable for Fueling Opioid Addiction in New York - WSJ
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Proneuron to sue Teva for billions in Copaxone damages - Globes
Swedish Biotech Faces Another Phase III Flop in Multiple Sclerosis
Teva must face government's kickback claims over Copaxone - judge | Reuters
Another setback for Teva's laquinimod in MS - PMLiVE
US regulator backs copycat version of Teva MS drug | Financial Times
Hope In A Pill
Pioglitazone Could Play a Role in MS Treatment | Everyday Health
Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion | FiercePharma
Teva fails to reclassify MS drug to thwart generics
Teva Pharmaceutical Facing EU Antitrust Investigation Over Patent Strategy for MS Drug - IP News Shots
Teva Pharmaceuticals - Wikiwand
FDA approves first generic version of epilepsy drug Sabril from Teva
Teva embroiled in Copaxone dosage levels dispute - Globes
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
New MS Drug Ocrevus Wins FDA Approval
Better Late Than Never: Novartis, Momenta Win FDA Approval for Delayed MS Drug | BioSpace
Teva's MS Drug Copaxone Looking for Approval in Japan - Jewish Business News
